Abbonarsi

Phosphatidylethanol (Peth) in Dried Blood Spots: Development, validation and comparison between LC-MS/MS and QTOF methods - 15/08/22

Doi : 10.1016/j.toxac.2022.06.065 
Christina Ververi 1, , Marta Massano 1, Enrico Gerace 2, Eugenio Alladio 3, Marco Vincenti 3, Alberto Salomone 3
1 Chemistry, University of Turin, Turin, Italy 
2 Centro regionale antidoping, Orbassano, Italy 
3 Chemistry, University of turin, centro regionale antidoping, Turin, Orbassano, Italy 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Aim

Validation of Phosphatidylethanol (Peth) in Dried Blood Spot (DBS) technique as a biomarker for routine diagnosis of alcohol abuse.

Introduction

According to recent studies, alcohol abuse in the population is increasing, forcing clinical and forensic toxicology laboratories to work towards effective and quick-turnout results techniques. In this context, detecting Peth, a relatively new biomarker, with the Dried Blood Spots, a micro sampling technique based on a capillary blood drop collection on a filter paper, may be the procedure of choice. Peth is a group of phospholipids serving as direct, non-oxidative alcohol biomarkers, only formed within the human body when ethanol is present. Peth concentrations provide information about a person's drinking behavior and offer a longer alcohol detection window up to 1 month. It is applicable as a complement to Ethyl glucuronide (EtG) for the better distinguishing of alcohol abusers from social drinkers.

Method

Blank whole blood drops were spiked with Peth 16:0–18:1 at six concentration levels (20, 50, 100, 200, 300, 500ng/mL) in three working sessions along five days. 30μl of blood was deposited on the DBS card and left for 3h drying at room temperature. After liquid extraction with 1mL of hexane, the supernatant was transferred into a fresh tube prior to evaporating the solvent under a nitrogen flow at room temperature. The dry residue was reconstituted in 30μl of acetonitrile and then injected. The detection of Peth was achieved with both UHPLC-QTOF-HRMS and UHPLC-MS/MS.

Results

Statistical evaluation of several validation parameters was executed, and the values obtained from the two different acquisition methods were found to be similar. Intra- and inter-day precision and accuracy were found to be lower than ±20% in both methods. The LOD and LOQ calculated with the Hubaux-Vos approach were 19.8 and 39.7ng/ml for, respectively, the QTOF and the MS/MS acquisition. Recovery, matrix effect and stability parameters from the analysis of Peth and its respective internal standards Peth-D5 were evaluated. A moderate ion suppression was observed, with final values between −2.7 and −14% (tested at the 20ng/ml level of concentration) and the method showed an extraction efficiency higher than 30% (tested at the 500ng/mL level of concentration). The two methods were also tested with real samples within an ongoing project and their performance was compared.

The extraction method and the DBS technique proved effective for the detection of Peth, with excellent results ensuring rapid assessment of the biomarker levels in whole blood. The precision calculated in the lower concentration range showed a slight upward deviation at 20 and 50ng/ml, which is negligible when an individual is assessed for chronic alcohol abuse (in this case, tentative cut-offs are set in the range of 200–270ng/ml). Due to the higher sensitivity obtained, the QTOF mass spectrometer proved adequate to be used for abstinence assessment in delicate clinical or forensic cases for example with newborns, organ transplant and driving relicensing.

Conclusion

Peth in DBS combined with high resolution instrumental analysis results show great potential for routine and research analysis. Thanks to this study, a larger detection window is opened thus providing the forensic toxicology laboratories an accurate, easy, sustainable, and fast technique for the challenge of alcohol abuse diagnosis.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2022  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 34 - N° 3S

P. S54 - Settembre 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • A method for the sensitive targeted screening of synthetic cannabinoids and opioids in whole blood by LC-QTOF with simultaneous suspect screening using HighResNPS.com
  • Stephen Trobbiani, Peter Stockham, Chris Kostakis
| Articolo seguente Articolo seguente
  • Practical high resolution mass spectrometry screening approach and propositions for adequate identification criteria as well as quality assurance and validation specifics
  • Sarah Sarah Wille, Aurélien Aurélien Boland, Vincent Vincent Di Fazio, Nele Nele Samyn

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.